Filing Details
- Accession Number:
- 0001209191-20-055033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-16 15:36:31
- Reporting Period:
- 2020-10-14
- Accepted Time:
- 2020-10-16 15:36:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1741830 | Kronos Bio Inc. | KRON | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1826661 | Trust Vivos Inter Revocable A. Inger & W. Norbert Bischofberger | C/O Kronos Bio, Inc. 1300 So. El Camino Real, Suite 300 San Mateo CA 94402 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-14 | 316,501 | $0.00 | 2,437,662 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2020-10-14 | 1,651,576 | $0.00 | 4,089,238 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2020-10-14 | 185,758 | $16.15 | 4,274,996 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2020-10-14 | 95,500 | $19.00 | 4,370,496 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series Seed Preferred Stock | Disposition | 2020-10-14 | 300,001 | $0.00 | 316,501 | $0.00 |
| Common Stock | Series A Preferred Stock | Disposition | 2020-10-14 | 1,565,475 | $0.00 | 1,651,576 | $0.00 |
| Common Stock | Convertible Promissory Note | Disposition | 2020-10-14 | 0 | $0.00 | 185,758 | $16.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | 2022-02-20 | No | 4 | C | Direct |
Footnotes
- Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- The convertible promissory note automatically converted into shares of the Issuer's common stock upon the closing of the Issuer's initial public offering.
Billionaire Hedge Funds
